Trust signals
> Reviewed by FormBlends Medical Team · Last updated May 2026 · 10 sources cited
Key Takeaways
- Compounded GLP-1 vials are labeled by mass in milligrams (mg) of active ingredient, but the standard injection syringe is marked in insulin units
- The conversion requires three pieces of information: the prescribed mg dose, the vial concentration in mg per mL, and the fact that 100 units equals 1 mL on a U-100 syringe
- The formula is straightforward: units = (mg dose / mg per mL concentration) x 100
- The mg-to-units calculator on FormBlends performs the math and shows the result on a visual syringe scale to reduce dosing errors
- The calculator is a verification tool that complements clinician and pharmacy dosing instructions, not a substitute for clinical guidance
Direct answer
The FormBlends mg-to-units calculator converts a prescribed GLP-1 dose in milligrams into the corresponding insulin syringe units, based on the concentration of the vial the patient receives. It exists because compounded medications are labeled in mass while injection syringes use a different measurement scale. The calculator does not prescribe doses, replace clinical instruction, or recommend self-dosing. It performs a unit conversion when the inputs are already known.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of contents
- The two measurement systems and why they collide
- The conversion math step by step
- Why this matters for compounded GLP-1 patients
- How brand pens avoid this problem
- How U-100 syringes are marked
- Common compounded vial concentrations
- Worked examples
- Common errors to avoid
- How the FormBlends calculator presents the math
- What the calculator does not do
- Patient-clinician workflow with the calculator
- FAQ
- Sources
The two measurement systems and why they collide
The mg-to-units question arises because two different measurement traditions meet in compounded GLP-1 administration.
System 1: The pharmacology system.
Medications are dosed by mass. A tablet contains a specific number of milligrams of active ingredient. A vial contains a specific concentration of active ingredient per milliliter. The prescription specifies the dose in milligrams. This is the standard system across medicine: pharmacology research, clinical trials, prescribing information, and pharmacy labeling.
For GLP-1 medications, doses are commonly described as 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg (semaglutide) or 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg (tirzepatide). These numbers refer to the mass of active ingredient delivered per dose.
System 2: The insulin syringe system.
Insulin syringes are marked in international units (IU). The unit was originally defined biologically: 1 unit of insulin was the amount required to produce a specific glucose-lowering effect in a standardized animal assay. Over time, the unit became standardized as 0.01 mL of a U-100 insulin formulation, where U-100 means "100 units per milliliter."
The U-100 syringe is marked along its length so each mark represents one unit (0.01 mL). A 1 mL U-100 syringe has 100 markings. A 0.5 mL syringe has 50 markings (still on the U-100 scale, just a shorter syringe).
When patients inject compounded GLP-1 medications, they typically use insulin syringes because the volumes are small (often 0.1 to 0.5 mL) and the U-100 scale provides precision for small-volume measurement. But the syringe markings are units, not milligrams, so the conversion math is necessary.
The conversion math step by step
The conversion has three steps:
Step 1: Identify the prescribed dose in milligrams.
This comes from the prescription. For example, a semaglutide dose of 0.5 mg, or a tirzepatide dose of 5 mg.
Step 2: Identify the vial concentration in mg per mL.
This is printed on the vial label or the pharmacy's instructions. For example, semaglutide 2.5 mg/mL means 2.5 milligrams of semaglutide are dissolved in each 1 mL of solution.
Step 3: Apply the formula.
Units = (mg dose / mg per mL) x 100
The division converts the mg dose into the volume of solution needed (in mL). The multiplication by 100 converts the mL volume into units on the U-100 syringe scale.
Example: A patient is prescribed 0.5 mg of semaglutide, and the vial is 2.5 mg/mL. The math: (0.5 / 2.5) x 100 = 20 units. The patient draws to the 20-unit mark on the U-100 insulin syringe.
This formula works for any concentration of any compounded GLP-1, as long as the inputs are correct.
Why this matters for compounded GLP-1 patients
Patients on brand GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) typically use prefilled pens. The pen has a dial that selects the dose in milligrams or in click-counts that correspond to specific mg doses. The user does not need to do unit math because the pen handles the conversion internally. Dialing "0.25 mg" delivers 0.25 mg, regardless of the internal concentration.
Compounded medications are different. They come in multi-dose vials with a known concentration, and the patient draws each dose using a syringe. The clinician and pharmacy provide dosing instructions, but the patient is responsible for drawing the correct volume each time.
The compounded approach offers cost advantages and flexibility, but introduces the unit conversion as a potential source of error. The dose calculator addresses this by performing the math reliably and presenting the result in a format that matches what the patient sees on the syringe.
This is why "mg to units" is such a common search term. Patients receive a prescription in mg, see a syringe marked in units, and need to bridge the two. The calculator exists to make that bridge less error-prone.
How brand pens avoid this problem
Brand GLP-1 manufacturers (Novo Nordisk for Ozempic and Wegovy, Eli Lilly for Mounjaro and Zepbound) designed their pen devices specifically to remove the unit conversion question.
- Ozempic pen: Multiple pen strengths are available (0.25/0.5 mg pen, 1 mg pen, 2 mg pen). The user dials the prescribed dose by turning a dial that clicks at the correct dose. The internal concentration is fixed for each pen, so the dial translates dose to volume automatically.
- Wegovy pen: Single-use pens with the dose pre-selected. Each pen contains one specific dose (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg). Users do not adjust the dose; they simply administer the entire pen contents.
- Zepbound pen and Mounjaro pen: Similar single-use pen design. Each pen contains one specific dose. Users administer the entire pen.
- Zepbound vials: Lilly released vial formulations of Zepbound in 2024. These come as single-dose vials with the dose pre-determined by vial selection, not by user measurement. Users withdraw the entire vial contents.
In all brand cases, the manufacturer absorbs the conversion problem by designing devices where mg and volume are coupled. Patients select the dose by pen choice or dial position, not by syringe measurement.
Compounded products take a different approach. The compounding pharmacy prepares a multi-dose vial at a known concentration. The patient (or caregiver) measures each dose using a syringe. The flexibility is real (dose adjustments don't require new pens) but the responsibility for measurement shifts to the patient.
How U-100 syringes are marked
Understanding the syringe scale is critical for using the calculator correctly. U-100 syringes are standardized:
- 1 mL syringe: Markings from 0 to 100 units. Each unit corresponds to 0.01 mL.
- 0.5 mL syringe: Markings from 0 to 50 units. Each unit corresponds to 0.01 mL. The barrel is shorter and narrower, which provides better precision for small doses.
- 0.3 mL syringe: Markings from 0 to 30 units. Often used for small doses where maximum precision is needed.
The unit markings on all U-100 syringes correspond to the same volume: 1 unit = 0.01 mL. The differences between syringe sizes are in capacity, not in the unit scale.
Some markings are labeled (every 10 or 5 units depending on syringe size) and intermediate marks are unlabeled. Patients should count carefully when drawing to an unlabeled mark.
Common compounded vial concentrations
Compounded GLP-1 medications come in several concentrations depending on the prescribing pattern and pharmacy formulation:
| Medication | Common concentrations | Notes |
|---|---|---|
| Compounded semaglutide | 2.5 mg/mL, 5 mg/mL | Higher concentrations allow smaller injection volumes at higher doses |
| Compounded tirzepatide | 5 mg/mL, 10 mg/mL | 10 mg/mL is more common at higher doses |
| Semaglutide with B12 | Varies by compounder | Some compounders add B12 or other adjuncts; concentration may differ |
| Tirzepatide with B12 | Varies by compounder | Same considerations as semaglutide variants |
The concentration determines the unit conversion. A 0.5 mg semaglutide dose corresponds to 20 units from a 2.5 mg/mL vial but only 10 units from a 5 mg/mL vial. The math is the same; the inputs change.
Patients switching from one compounded supplier to another may receive vials at different concentrations. The mg dose stays the same, but the unit measurement changes. This is a known source of dosing errors when patients assume the unit measurement carries over.
Always verify the concentration on the vial label or in the pharmacy's dispensing instructions. The calculator requires this input to produce the correct result.
Worked examples
Example 1: Semaglutide 0.25 mg starter dose from a 2.5 mg/mL vial.
Math: (0.25 / 2.5) x 100 = 10 units
The patient draws to the 10-unit mark.
Example 2: Semaglutide 0.5 mg from a 2.5 mg/mL vial.
Math: (0.5 / 2.5) x 100 = 20 units
The patient draws to the 20-unit mark.
Example 3: Semaglutide 1 mg from a 5 mg/mL vial.
Math: (1 / 5) x 100 = 20 units
The patient draws to the 20-unit mark. Note that the unit count is the same as Example 2, even though the mg dose is different, because the concentration is higher.
Example 4: Tirzepatide 2.5 mg starter dose from a 5 mg/mL vial.
Math: (2.5 / 5) x 100 = 50 units
The patient draws to the 50-unit mark. A 0.5 mL syringe would be filled completely; a 1 mL syringe would be filled halfway.
Example 5: Tirzepatide 5 mg from a 10 mg/mL vial.
Math: (5 / 10) x 100 = 50 units
Again 50 units, because the higher concentration offsets the higher mg dose.
Example 6: Tirzepatide 10 mg from a 10 mg/mL vial.
Math: (10 / 10) x 100 = 100 units
The patient draws to the 100-unit mark, which fills a 1 mL syringe completely. Doses requiring more than 100 units of a given concentration sometimes require two injections or a different vial concentration.
Common errors to avoid
The most frequent errors in mg-to-units conversion:
Error 1: Using the wrong concentration.
If the prescribed dose was calculated for one concentration but the patient receives a vial at a different concentration, the unit count is wrong. This happens most often when patients switch pharmacies or when a pharmacy changes its standard concentration. Always check the new vial label before injecting.
Error 2: Confusing units with mg.
Some patients draw to a unit mark that matches their mg dose (e.g., drawing 5 units for a 5 mg dose). This is almost always wrong, except in rare specific concentrations. The unit number rarely matches the mg number directly.
Error 3: Confusing U-40 and U-100 syringes.
Older insulin syringes used the U-40 scale (40 units per mL). Most modern syringes are U-100. Using a U-40 syringe with a calculation for U-100 produces a 2.5-fold overdose. Always confirm the syringe is U-100 (labeling on the package).
Error 4: Decimal point errors.
Reading the prescription as 0.5 mg versus 5 mg matters. Reading the concentration as 2.5 mg/mL versus 25 mg/mL matters. Decimal point errors produce 10-fold dosing errors. Verify by re-reading the prescription, the vial, and the calculator output.
Error 5: Mixing concentrations during a vial change.
Patients who titrate up may receive a new vial at a different concentration designed for the higher dose. The old unit count no longer applies. Recalculate when changing vials.
Error 6: Skipping verification.
The calculator produces a number. Patients should compare that number to the prescribing clinician's written instructions before injecting. Both should agree. If they don't, contact the clinician before proceeding.
How the FormBlends calculator presents the math
The calculator interface accepts three inputs:
- The prescribed mg dose (typed or selected from common values)
- The vial concentration in mg/mL (typed or selected from common compounded concentrations)
- The syringe type (U-100 by default)
The output displays:
- The corresponding unit count
- The corresponding mL volume
- A visual representation of where to draw on a typical syringe scale
- A reminder to verify with the prescribing clinician
The visual element is important. Numeric output alone can be misread. Showing the syringe scale with the fill level highlighted provides a second verification path that catches errors the user might miss in pure numeric form.
The calculator does not store patient information, does not transmit data to clinicians, and does not adjust based on patient characteristics. It performs a pure unit conversion. Clinical decisions remain with the prescribing clinician.
What the calculator does not do
To be clear about the scope:
- The calculator does not select a dose. The prescribed dose comes from a clinician.
- The calculator does not adjust for patient weight, BMI, or response. Dose adjustments are clinical decisions.
- The calculator does not replace pharmacy instructions. The pharmacy provides the authoritative volume per dose.
- The calculator does not verify the medication identity, expiration, or sterility. These are clinical and pharmacy responsibilities.
- The calculator does not detect overdoses or contraindications. Clinical safety is a clinician function.
The calculator is a math tool. It assumes the prescribed dose is appropriate, the vial concentration is correctly identified, and the syringe is the correct type. Within those assumptions, it computes the unit volume reliably.
Patient-clinician workflow with the calculator
The intended use pattern:
Step 1: The clinician prescribes a specific dose (e.g., semaglutide 0.5 mg weekly).
Step 2: The pharmacy fills the prescription with a vial of a known concentration (e.g., semaglutide 2.5 mg/mL) and provides dispensing instructions.
Step 3: The patient receives the medication and reads the dispensing instructions, which typically include the unit measurement (e.g., "draw to 20 units on a U-100 insulin syringe").
Step 4: Before the first injection, the patient can use the calculator to verify the unit count matches the pharmacy instructions. If they agree, proceed. If they don't agree, contact the pharmacy or clinician.
Step 5: At each subsequent injection, the patient draws to the same unit mark, assuming no dose change.
Step 6: When the clinician adjusts the dose (titration steps), the patient re-runs the calculator with the new mg dose to determine the new unit count.
Step 7: When the pharmacy provides a new vial at a different concentration (sometimes occurring during titration to a higher dose), the patient re-runs the calculator with the new concentration.
The pattern is: calculator supplements rather than replaces clinical guidance. The clinician decides the dose. The pharmacy provides the medication and instructions. The calculator helps the patient confirm the math.
FAQ
Why are GLP-1 vials labeled in mg but syringes measured in units? The medication is measured by mass (mg), which is the standard pharmacology unit. The syringe was designed for insulin and is marked in international units (IU), where 100 units equals 1 mL on a U-100 syringe.
What is the conversion formula? Units = (desired mg dose / vial concentration in mg per mL) x 100. The 100 comes from the U-100 syringe scale.
Is the calculator a substitute for clinical guidance? No. The calculator helps with the math once a clinician has prescribed a specific dose. The prescribed dose, vial concentration, and dosing schedule all come from the patient's clinician.
What if my vial has a different concentration? Compounded GLP-1 vials come in several concentrations. Common semaglutide concentrations include 2.5 mg/mL and 5 mg/mL. Common tirzepatide concentrations include 5 mg/mL and 10 mg/mL. Set the calculator to your specific vial's concentration.
Why is this math confusing? The math crosses three units: milligrams (mass), milliliters (volume), and insulin units (volume on the U-100 scale). The conversion is straightforward but easy to get wrong under stress.
What is a U-100 insulin syringe? A U-100 syringe is marked so that 100 units equals 1 milliliter. The scale was designed for insulin, but the marking is useful for precise small-volume measurement of any compatible medication.
Should patients do this math themselves? Patients on compounded GLP-1 medications typically receive specific dosing instructions from the prescribing clinician or pharmacy. The calculator is a verification tool, not a self-dosing aid.
What happens if I draw the wrong amount? Drawing too little produces a sub-therapeutic dose and reduced effectiveness. Drawing too much can produce severe nausea, vomiting, dehydration, and may require medical attention. Always verify your dose with the prescribing clinician's instructions.
Does the calculator work for tirzepatide? Yes. The same formula applies to any compounded GLP-1 medication. Enter the mg dose and the concentration of the specific vial.
Can I use the calculator for brand Ozempic or Wegovy? Brand pens have built-in dose selection that does not require external calculation. The calculator is intended for compounded vials where the patient measures from a multi-dose vial.
What if the unit count is more than 100? Doses requiring more than 100 units of a given concentration may require a larger syringe, a higher-concentration vial, or two separate injections. This is uncommon at standard doses but can occur at high tirzepatide doses with lower-concentration vials. Discuss with the pharmacy.
Should I double-check the calculator output with my pharmacy? Yes, especially for the first injection from a new vial or after any dose change. The pharmacy's dispensing instructions are the authoritative source. The calculator should agree with those instructions.
Sources
- U.S. Food and Drug Administration. Section 503A of the Federal Food, Drug, and Cosmetic Act. FDA Compounding Quality Act Guidance. 2014.
- U.S. Pharmacopeia. USP 797 Pharmaceutical Compounding: Sterile Preparations. Current Edition.
- American Diabetes Association. Standards of Medical Care in Diabetes 2024: Insulin Administration. Diabetes Care. 2024.
- Eli Lilly and Company. Mounjaro Pen Instructions for Use. Revised 2024.
- Novo Nordisk. Ozempic Pen Instructions for Use. Revised 2024.
- Becton Dickinson. BD Insulin Syringe Product Information. U-100 Syringe Specifications.
- Institute for Safe Medication Practices. Insulin Pen and Syringe Safety: Best Practice Guidelines. ISMP. 2022.
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384(11):989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387(3):205-216.
- National Association of Boards of Pharmacy. Resource Guide for Compounded Sterile Preparations. NABP. 2023.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that links patients with independent licensed clinicians and state-licensed 503A compounding pharmacies. The mg-to-units calculator is an informational tool. It does not provide medical advice, dosing recommendations, or clinical decisions. All clinical determinations are made by qualified providers, and pharmacy-provided dispensing instructions are the authoritative source for dose administration.
Compounded Medication Notice. Compounded semaglutide and compounded tirzepatide are prepared by state-licensed compounding pharmacies for individual patient prescriptions. Compounded medications are not FDA-approved and are not interchangeable with brand Ozempic, Wegovy, Mounjaro, or Zepbound from a regulatory standpoint. The same active molecule is present, but the regulatory framework differs.
Results Disclaimer. The conversion formula and example calculations on this page assume U-100 insulin syringes and standard compounded concentrations. Use of different syringe types or concentrations changes the math. Patients should always verify dose calculations against their pharmacy's dispensing instructions and their clinician's prescription.
Trademark Notice. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. BD and the U-100 insulin syringe terminology are trademarks of Becton Dickinson or used as standard pharmaceutical terms. FormBlends is not affiliated with Novo Nordisk, Eli Lilly, Becton Dickinson, or any pharmaceutical manufacturer.